The US FDA has issued six inspectional observations in Form 483 for Cipla's manufacturing facility in Goa. The inspection took place between June 10 to June 21, 2024. Cipla's Goa plant has been under a warning letter since February 2020.
U.S. #FDA inspection at #Cipla's manufacturing unit in Patalganga, Maharashtra classified as Voluntary Action Indicated: Exchange Filing.
U.S. #FDA issues establishment inspection report for #AlkemLaboratories manufacturing facility at Baddi.
U.S. FDA inspection at #ShilpaMedicare's Hyderabad bio analytical facility closes with zero observations: Exchange filing
#JustIn | #USFDA issues an Establishment Inspection Report (EIR) for #AlkemLab's manufacturing facility in Baddi. The Inspection has been classified as Voluntary Action Indicated (VAI) https://t.co/PaqkuBBXUU
#Lupin: Gets Establishment Inspection Report (EIR) from the USFDA for its Somerset manufacturing facility with a Voluntary Action Indicated (VAI) status. The facility was inspected between May 7 to May 17, 2024.
#Cipla: USFDA issues form 483 with six observations for its Goa facility. The plant was inspected between June 10 to June 21, 2024. The Goa plant has been under a warning letter since February 2020. The company's Indore plant has been under a warning letter since November 2023.
Cipla receives six observations from USFDA after Goa facility inspection https://t.co/ikm019g7Gl
Check out the latest FDA Roundup, our at-a-glance summary of agency updates: https://t.co/oJIeAA7oTy Today, we published final guidance titled Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection. https://t.co/zujYWU3JKn Yesterday,… https://t.co/fuq7wftAVd
U.S. #FDA inspection at #Cipla's manufacturing facility in #Goa ends with 6 observations.
#JustIn | US FDA issues six inspectional observations in Form 483 for #Cipla's Goa manufacturing facility https://t.co/S6wAtxsOUq
JUST IN | Cipla gets 6 observations after USFDA inspection at company's mfg facility in Goa: Agencies @US_FDA #Cipla #StockMarket https://t.co/LpwXPwaWv3